Cervical Precancerous Lesions and Cancer among Patients in the Gynaecology Outpatient Department at a Tertiary Hospital in South Africa

  • Hank, Edward (Clinical Manager, Rahima Moosa Hospital) ;
  • Hoque, Muhammad Ehsanul (Graduate School of Business and Leadership, University of KwaZulu- Natal (Westville Campus)) ;
  • Zungu, Lindiwe (Department of Health Studies, University of South Africa)
  • Published : 2013.08.30


Background: The purpose of this study was to determine proportional rates of cervical precancerous lesions and cancer, and associations with socio-demographic variables, HIV status, and CD4 cell count. Materials and Methods: A retrospective comparative study was conducted targeting the medical records of all women over age 18 that were diagnosed histologically through colposcopy with cervical precancerous lesions and cancer from 1 December 2011 to 30 November 2012. Results: A total of 313 patient records were used for data analysis. The average age was 39.1 (SD=2.04) years. More than a third (37.1%) of the patients had CIN III or cervical cancer. There was a significant association between age, CD4 cell count, HIV status, and cervical lesions (p<0.05). Age was found to be an influential predictor of cervical lesions (OR=0.67, 95%CI: 0.46-0.98). Conclusions: There exists an association between age and cervical lesions, with presentation of cervical precancerous lesions and cervical cancer at a younger age among HIV reactive patients. The National Guidelines should be brought in line with the National HIV Counseling and Testing Policy to offer Pap smears to all sexually active women that test HIV reactive during routine HIV Testing.


Cervical precancerous lesions and cancer;CD4 cell count;HIV status;national guidelines;South Africa


  1. Benard VB, Watson M, Castle PE, Saraiya M (2012). Cervical carcinoma rates among young females in the United States. Obstet Gynecol, 120, 1117-23.
  2. Cancer Association of South Africa: CANSA (2008). National Cancer Registry (NCR) Report (2000-2001). Bedfordview, Johannesburg, Gauteng, South Africa.
  3. Chankapa YD, Pal R, Tsering D (2011). Correlates of cervical cancer screening among underserved women. Indian J Cancer, 48, 40-6.
  4. Fernandes JV, Meissner RV, Carvalho MGF, et al (2010). Prevalence of human papillomavirus (HPV) in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil. BMC Res Notes, 3, 96.
  5. Francis SA, Battle-Fisher M, Liverpool J, et al (2011). A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine, 29, 8760-5.
  6. Gupta S, Sodhani P, Halder K, et al (2008). Age trends in pre-cancerous and cancerous lesions of the uterine cervix in a cytology screening programme: what should be the target age group for a major thrust of screening in resource-limited settings? Cytopathology, 19, 106-10.
  7. Ho GY, Einstein MH, Romney SL, et al (2011). Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: managed by watchful waiting. J Low Genit Tract Dis, 15, 268-75.
  8. Jemal A, Bray F, Center Mm, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  9. Keller MJ, Burk RD, Xie X, et al (2012). Risk of Cervical Precancer and Cancer among HIV-Infected Women with Normal Cervical Cytology and No Evidence of Oncogenic HPV Infection. JAMA, 308, 362-9.
  10. Kim JW, Song SH, Jin CH, et al (2012). Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia. J Int Med Res, 40, 486-96.
  11. Kruger TF, Botha MH (2008). Clinical Gynaecology. Juta UCT Press, Cape Town.
  12. Lawrie D, Coetzee LM, Becker P, et al (2009). Local reference ranges for full blood count and CD4 lymphocyte count testing. S Afr Med J, 99, 243-8.
  13. Levisohn D, Reid R, Burt AD, et al (2008). Muir's Textbook of Pathology, Fourteenth Edition, CRC Press, London.
  14. McKenzie KP, Rogers RK, Njoroge JW, et al (2011). Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in Kenya. Current HIV Res, 9, 180-5.
  15. Memiah P, Mbuthia Y, Kiiru G, et al (2012). Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings. AIDS Research and Treatment, (in press).
  16. Moodley JR, Constant D, Hoffman M, et al (2009). Human papillomavirus prevalence, viral load and pre cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional Study. BMC Cancer, 9, 275.
  17. Moyer VA (2012). Screening for cervical cancer: US preventive services task force recommendation statement. Ann Intern Med, 156, 880-91.
  18. National Department of Health: NDOH (2000). National Guidelines on Cervical Screening Programme. National Department of Health. Pretoria.
  19. National Department of Health (NDOH), (2010). The South African Antiretroviral Treatment Guidelines. National Department of Health. Pretoria.
  20. Obure J, Olola O, Swai B, et al (2009). Prevalence and severity of cervical squamous intraepithelial lesion in a tertiary hospital in northern Tanzania. Tanzan J Health Res, 11, 163-9.
  21. Omar T, Schwartz S, Hanrahan C, et al (2011). Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS, 25, 87-94.
  22. Wentzensen N, Walker J, Schiffman M, et al (2013). Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer, 132, 148-54.
  23. World Health Organization: WHO (2010). Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. Geneva, Switzerland.

Cited by

  1. A Systematic Review of Economic Aspects of Cervical Cancer Screening Strategies Worldwide: Discrepancy between Economic Analysis and Policymaking vol.15, pp.19, 2014,
  2. Assessment of Cervical Cytological Data in Albanian Females vol.15, pp.5, 2014,
  3. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective vol.16, pp.1, 2016,